Biopharma Finishes 2024 Strong With ‘Robust’ VC, Upfront Payments: JP Morgan

J.P. Morgan releases its annual look-ahead days before the entire biopharma industry descends on San Francisco for the annual J.P. Morgan Healthcare Conference.

Scroll to Top